Publications

Technology Status Evaluation Reports

Technology status evaluation reports provide a review of existing, new, or emerging endoscopic technologies that have an impact on the practice of GI endoscopy. Reports are based on an evaluation of medical literature and a search of the MAUDE (U.S. Food and Drug Administration Center for Devices and Radiological Health) database to identify the reported adverse events of a given technology. When financial guidance is indicated, the most recent coding data and list prices at the time of publication are provided. Technology status evaluation reports are scientific reviews based on expert consensus and are provided solely for educational and informational purposes.

The members of the ASGE Technology Committee provide ongoing conflict of interest (COI) disclosures throughout the development and publication of all documents in accordance with the ASGE Policy for Managing Declared Conflicts of Interests.

If you have any questions or suggestions, please contact Customer Support at Info@asge.org.

The following information is intended only to provide general information and not as a definitive basis for diagnosis or treatment in any particular case. It is very important that you consult your doctor about your specific condition.

Newly Published
Upper Endoscopy
All assessments
RETs
PIVIs

ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the ASGE Technology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an ASGE Preservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP

ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the ASGE Technology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an ASGE Preservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP
Colonoscopy
All assessments
PIVIs

ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the ASGE Technology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an ASGE Preservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP
Bariatric Endoscopy
All assessments
RETs
PIVIs

ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the ASGE Technology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an ASGE Preservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP

ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the ASGE Technology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an ASGE Preservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP

ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the ASGE Technology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an ASGE Preservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP
ERCP
EUS
All assessments
RETs

ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the ASGE Technology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an ASGE Preservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP
Endoscope Design/Reprocessing
All assessments 
RETs
Other Imaging Techniques
All assessments
RETs
Therapeutic GI Devices
All assessments
RETs
Miscellaneous
All assessments
RETs

Submucosal injection fluid and tattoo agents 2024

Nov 5, 2024, 11:24
Title : Submucosal injection fluid and tattoo agents 2024
URL :
Doi org link : https://www.giejournal.org/article/S0016-5107(24)03347-9/fulltext
Volume : Gastrointest Endosc 2024; Volume 100, Issue 5; p797-806 DOI: 10.1016/j.gie.2024.07.002
Select a choice : Keep
Content created :
ExternalPK :
File size :
Categories :
Tags :
  • misc

In Progress Technology Assessments

Endoscopic closure devices

2025

iStock-1189305225(1)

Practice Guidelines

View all